Expertise in
1
conditions

Thomas Guimard

La Roche, FR 
Expertise in
1
conditions
La Roche, FR 

Overview

Thomas Guimard practices practicing medicine in La Roche, France.

Mr. Guimard is highly rated in 1 condition, according to our data. His clinical expertise encompasses Endocarditis, Bacterial Meningitis, Eschar, and Meningitis.

He is actively involved in clinical research, co-authoring 34 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

La Roche, France
Other Locations
France
CH de Bayonne
Bayonne, France
CHU Angers
Angers, France
1, Place Alexis Ricordeau, Nantes, 44093, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (Relais Oral Dans le Traitement Des Endocardites à Staphylocoques Multi-sensibles)
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (Relais Oral Dans le Traitement Des Endocardites à Staphylocoques Multi-sensibles)
Enrollment Status: Completed
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug
Study Drugs: Levofloxacin, Rifampicin
Study Phase: Phase 3
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus (Relais Oral Dans le Traitement Des Endocardites à Streptocoques Multi-sensibles)
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus (Relais Oral Dans le Traitement Des Endocardites à Streptocoques Multi-sensibles)
Enrollment Status: Completed
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug
Study Drug: Amoxicillin
Study Phase: Phase 3
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Enrollment Status: Completed
Publish Date: July 05, 2022
Intervention Type: Drug
Study Drug: Enoxaparin
Study Phase: Phase 3
EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin in the Treatment of Staphylococcal Bone and Joint Infections
EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin in the Treatment of Staphylococcal Bone and Joint Infections
Enrollment Status: Completed
Publish Date: August 23, 2021
Intervention Type: Drug
Study Phase: Phase 4
Early Oral Switch Therapy in Low-risk Staphylococcus Aureus Bloodstream Infection
Early Oral Switch Therapy in Low-risk Staphylococcus Aureus Bloodstream Infection
Enrollment Status: Completed
Publish Date: May 27, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

34 Total Publications

Longitudinal gut microbiome dynamics are associated with clinical outcome and toxicity during ibrutinib therapy.
Longitudinal gut microbiome dynamics are associated with clinical outcome and toxicity during ibrutinib therapy.
Journal: Gut microbes
Published: April 19, 2026

Frequently Asked Questions about Thomas Guimard

Is Thomas Guimard a top-rated expert for Endocarditis?

MediFind is an objective health platform that identifies experts based on real-world data. Thomas Guimard is classified as an Advanced expert for Endocarditis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thomas Guimard participate in research or clinical trials?

Yes. Thomas Guimard has published 34 articles and abstracts on conditions like Endocarditis. You can view a list of Thomas Guimard's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Guimard's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile